Inhibition of PPARγ in myeloid-lineage cells induces systemic inflammation, immunosuppression, and tumorigenesis.
about
Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokinesPhenotype, development, and biological function of myeloid-derived suppressor cellsMyeloid-derived suppressor cells in the tumor microenvironment: expect the unexpectedThe transcriptome of lung tumor-infiltrating dendritic cells reveals a tumor-supporting phenotype and a microRNA signature with negative impact on clinical outcomeMyeloid-derived suppressor cells are involved in lysosomal acid lipase deficiency-induced endothelial cell dysfunctions.Activation of mTOR pathway in myeloid-derived suppressor cells stimulates cancer cell proliferation and metastasis in lal(-/-) micePredictive computational modeling of the mucosal immune responses during Helicobacter pylori infectionRole of an indole-thiazolidine molecule PPAR pan-agonist and COX inhibitor on inflammation and microcirculatory damage in acute gastric lesionsTranscriptional regulation of myeloid-derived suppressor cells.A core of kinase-regulated interactomes defines the neoplastic MDSC lineage.Critical role of PPARγ in myeloid-derived suppressor cell-stimulated cancer cell proliferation and metastasis.Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent manner.Inhibiting MDSC differentiation from bone marrow with phytochemical polyacetylenes drastically impairs tumor metastasis.PPARγ maintains ERBB2-positive breast cancer stem cells.Peroxisome Proliferator-Activated Receptor Modulation during Metabolic Diseases and Cancers: Master and Minions.PPAR-γ/IL-10 axis inhibits MyD88 expression and ameliorates murine polymicrobial sepsisLysosomal acid lipase in mesenchymal stem cell stimulation of tumor growth and metastasis.Myeloid-derived suppressor cells: mechanisms of action and recent advances in their role in transplant tolerance.Tumor microenvironment and myeloid-derived suppressor cells.History of myeloid-derived suppressor cells.Myeloid-Derived Suppressor Cells and Therapeutic Strategies in Cancer.Hepatocyte-Specific Expression of Human Lysosome Acid Lipase Corrects Liver Inflammation and Tumor Metastasis in lal(-/-) Mice.Mechanisms overseeing myeloid-derived suppressor cell production in neoplastic disease.Tyrosine kinase inhibitors reprogramming immunity in renal cell carcinoma: rethinking cancer immunotherapy.Tissue Phthalate Levels Correlate With Changes in Immune Gene Expression in a Population of Juvenile Wild Salmon.Polarization of Monocytic Myeloid-Derived Suppressor Cells by Hepatitis B Surface Antigen Is Mediated via ERK/IL-6/STAT3 Signaling Feedback and Restrains the Activation of T Cells in Chronic Hepatitis B Virus Infection.Lysosomal acid lipase in cancer.Myeloid-derived suppressor cells interact with tumors in terms of myelopoiesis, tumorigenesis and immunosuppression: thick as thieves.Lung Epithelial Cell-Specific Expression of Human Lysosomal Acid Lipase Ameliorates Lung Inflammation and Tumor Metastasis in Lipa(-/-) MiceAntitumor effect of paclitaxel is mediated by inhibition of myeloid-derived suppressor cells and chronic inflammation in the spontaneous melanoma model.Oral administration of soluble β-glucans extracted from Grifola frondosa induces systemic antitumor immune response and decreases immunosuppression in tumor-bearing mice.Epidermal PPARγ influences subcutaneous tumor growth and acts through TNF-α to regulate contact hypersensitivity and the acute photoresponse.Antagonism of PPAR-γ signaling expands human hematopoietic stem and progenitor cells by enhancing glycolysis.Therapeutic advantage of anti-VAP-1 over anti-α4 integrin antibody in concanavalin a-induced hepatitis.Maternal micronutrients, omega-3 fatty acids, and placental PPARγ expression.Myeloid-specific expression of Stat3C results in conversion of bone marrow mesenchymal stem cells into alveolar type II epithelial cells in the lung.
P2860
Q27001148-AEA5A42D-3598-49CA-AB2F-0E26197C0FFBQ28079046-EF9C9F71-6C96-4C35-BC95-10776FFC2B9CQ28084627-B0A5B787-93AD-48E7-9EC9-C45EBB853E2DQ29248715-1C2DEA9F-C423-49CA-AA7E-6F9CBF896C4EQ33992611-D24B1BF5-A5D7-45BE-86CB-75473FCC3622Q34624523-56A33304-E0A8-405C-888A-FDB8B8058F98Q34988965-F0906AF3-D5E2-4703-A013-8E8559E04169Q35017091-B28ED8E2-BE10-4645-A8EF-3B9DABDB1A4AQ36322351-E1013C0B-A28B-4485-9698-17468B9C65E9Q36413721-3990F317-0BD7-4E7D-88E5-237078EB94AFQ36738890-14C28671-31A7-4FD5-92F4-E8A36FF68578Q37203714-3B03DEEA-9A7F-417E-B92C-5697C987CB0BQ37421798-BBCF077F-D276-43D3-BDC5-486C17065B6CQ37501777-B5327D9C-4398-4249-92E6-7457ED0093BCQ37578702-124868AD-100F-43C4-B205-46A42C4391BDQ37620186-A8F1BCB9-F79F-4EB7-9AF9-EDD044D0A503Q37641570-30456066-5962-4158-B0E4-6C29DFCDEFA9Q38028470-0C1E28BE-6888-49F0-BA79-8E599A1B6EEDQ38067642-0ABB2AE6-66CC-4116-A734-C3C92E549CFDQ38141522-229F37E8-176A-4C68-8BED-114530048764Q38528814-85150E20-71EA-4DC5-87A3-FD6D961C43AFQ38849047-900C37F2-8524-4715-8FBC-8B70C7A60F25Q39146128-A3482949-5160-465D-9473-D2E610255B85Q39242385-465E422E-56E5-4FA2-A68B-0A3B5A1CC382Q40675284-4119D3CB-BB47-4259-A256-686EB00734AFQ40976617-89582E49-25F2-40A8-97ED-3B51BB130539Q41791244-5CE77F2E-AD84-4652-9D16-6551D00E4CB4Q41952605-086BE5DA-108D-42E6-A6BB-CCED549977FBQ42044284-A713888F-62B1-4650-94D0-4AA8C05D9F9FQ43243177-66A01F06-CA36-4165-9FCB-8334603EC676Q45344940-922E3264-06C1-47A5-8691-C98AA0166634Q47139765-4F6A15DC-B63D-41E8-A09A-F7CB931F073DQ49612432-E4F15741-B494-4CFF-9E52-B985F6FC4C52Q50981184-B1F43504-2E33-4C88-A488-293ABB03B45EQ51144946-D3E89A20-384C-4A99-977F-E85CBEDFFDBCQ54298113-B572D1B4-6CF6-4FB6-B28A-1FB5C9081C0B
P2860
Inhibition of PPARγ in myeloid-lineage cells induces systemic inflammation, immunosuppression, and tumorigenesis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Inhibition of PPARγ in myeloid ...... uppression, and tumorigenesis.
@ast
Inhibition of PPARγ in myeloid ...... uppression, and tumorigenesis.
@en
type
label
Inhibition of PPARγ in myeloid ...... uppression, and tumorigenesis.
@ast
Inhibition of PPARγ in myeloid ...... uppression, and tumorigenesis.
@en
prefLabel
Inhibition of PPARγ in myeloid ...... uppression, and tumorigenesis.
@ast
Inhibition of PPARγ in myeloid ...... uppression, and tumorigenesis.
@en
P2093
P2860
P1433
P1476
Inhibition of PPARγ in myeloid ...... uppression, and tumorigenesis.
@en
P2093
Lingyan Wu
Magdalena Czader
Oded Foreman
Reuben Kapur
P2860
P304
P356
10.1182/BLOOD-2011-06-363093
P407
P577
2011-11-03T00:00:00Z